doxorubicin hydrochloride
Generic: doxorubicin hydrochloride
Labeler: zydus pharmaceuticals usa inc.Drug Facts
Product Profile
Brand Name
doxorubicin hydrochloride
Generic Name
doxorubicin hydrochloride
Labeler
zydus pharmaceuticals usa inc.
Dosage Form
INJECTABLE, LIPOSOMAL
Routes
Active Ingredients
doxorubicin hydrochloride 2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
70710-1530
Product ID
70710-1530_c2f54fd5-c67b-4f4e-9666-d35bd93405d8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212299
Listing Expiration
2026-12-31
Marketing Start
2020-09-14
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
707101530
Hyphenated Format
70710-1530
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
doxorubicin hydrochloride (source: ndc)
Generic Name
doxorubicin hydrochloride (source: ndc)
Application Number
ANDA212299 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1530-1) / 10 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "c2f54fd5-c67b-4f4e-9666-d35bd93405d8", "openfda": {"upc": ["0370710153113", "0370710153014"], "unii": ["82F2G7BL4E"], "rxcui": ["1790115", "1790127"], "spl_set_id": ["15a84bd6-b565-4722-bb92-e4c919620a90"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1530-1) / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "70710-1530-1", "marketing_start_date": "20200914"}], "brand_name": "DOXORUBICIN HYDROCHLORIDE", "product_id": "70710-1530_c2f54fd5-c67b-4f4e-9666-d35bd93405d8", "dosage_form": "INJECTABLE, LIPOSOMAL", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "70710-1530", "generic_name": "doxorubicin hydrochloride", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DOXORUBICIN HYDROCHLORIDE", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA212299", "marketing_category": "ANDA", "marketing_start_date": "20200914", "listing_expiration_date": "20261231"}